Novo Nordisk A/S (NONOF)
OTCMKTS · Delayed Price · Currency is USD
53.86
-1.66 (-2.99%)
Sep 12, 2025, 3:54 PM EDT
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of $242.99 billion as of September 12, 2025. Its market cap has decreased by -59.49% in one year.
Market Cap
242.99B
Enterprise Value
255.61B
Revenue
49.11B
Ranking
n/a
PE Ratio
13.90
Stock Price
$53.86
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 7.15B to 242.99B, an increase of 3,300.14%. That is a compound annual growth rate of 13.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 242.99B | -37.02% |
| Dec 30, 2024 | 385.82B | -16.41% |
| Dec 29, 2023 | 461.55B | 51.61% |
| Dec 30, 2022 | 304.43B | 19.34% |
| Dec 30, 2021 | 255.09B | 56.58% |
| Dec 30, 2020 | 162.91B | 19.30% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 739.37M |
| Tian'an Technology Group | 675.94M |
| Glass House Brands | 608.81M |
| CytoDyn | 424.27M |
| Northwest Biotherapeutics | 378.39M |
| American Oncology Network | 353.52M |